Speaker illustration

Doctor Khava Dzaurova

National Medical Research Center of Cardiology, Moscow (Russian Federation)

Member of:

European Heart Rythm Association

Efficiency and safety of the modified protocol for cardioversion of atrial fibrillation using the antiarrhythmic drug niferidil. First results of clinical use.

Event: ESC Congress 2021 - The Digital Experience

Topic: Antiarrhythmic Pharmacotherapy

Session: Pharmacology and pharmacotherapy e-posters

Thumbnail

This platform is supported by

logo Novo Nordisk